Status:
COMPLETED
Chronic Kidney Disease and Non-alcoholic Fatty Liver Diseases
Lead Sponsor:
Sohag University
Conditions:
Chronic Kidney Diseases
NAFLD
Eligibility:
All Genders
20-80 years
Brief Summary
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide. This disease reportedly affects up to 30% of the general population in Western countries, especia...
Detailed Description
This study will be conducted on 100 patients 70 patients diagnosed to has NAFLD by ultrasonography presented to the outpatient clinic of Sohag University Hospital, and A control group of 30 healthy vo...
Eligibility Criteria
Inclusion
- patients diagnosed to has NAFLD by ultrasonography presented to the outpatient clinic of Sohag University Hospital
Exclusion
- Diabetic patients.
- Hypertensive patients.
- Other causes of chronic liver disease rather than NAFLD.
Key Trial Info
Start Date :
February 28 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 15 2021
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04779905
Start Date
February 28 2021
End Date
September 15 2021
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mona Mohammed Abdelrahman
Sohag, Egypt